Claus Bus

762 total citations
9 papers, 301 citations indexed

About

Claus Bus is a scholar working on Molecular Biology, Infectious Diseases and Biomedical Engineering. According to data from OpenAlex, Claus Bus has authored 9 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Biomedical Engineering. Recurrent topics in Claus Bus's work include Advanced biosensing and bioanalysis techniques (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and RNA Interference and Gene Delivery (2 papers). Claus Bus is often cited by papers focused on Advanced biosensing and bioanalysis techniques (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and RNA Interference and Gene Delivery (2 papers). Claus Bus collaborates with scholars based in Denmark, Germany and Poland. Claus Bus's co-authors include Jørgen Kjems, Joachim W. Engels, Jesper B. Bramsen, Romualdas Smičius, Dalibor Odadzic, Thomas B. Hansen, Piet Herdewijn, Jyoti Chattopadhyaya, Malgorzata Maria Pakula and Niels Langkjær and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Neurobiology of Aging.

In The Last Decade

Claus Bus

7 papers receiving 296 citations

Peers

Countries citing papers authored by Claus Bus

Since Specialization

Citations

This map shows the geographic impact of Claus Bus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claus Bus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claus Bus more than expected).

Fields of papers citing papers by Claus Bus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claus Bus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claus Bus. The network helps show where Claus Bus may publish in the future.

Co-authorship network of co-authors of Claus Bus

This figure shows the co-authorship network connecting the top 25 collaborators of Claus Bus. A scholar is included among the top collaborators of Claus Bus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claus Bus. Claus Bus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Diagnosis and Staging of Metabolic Dysfunction-Associated Steatotic Liver Disease Using Biomarker-Directed Aptamer Panels 2025 ·Biomolecules ·(unknown), (unknown), (unknown), Daniel M. Dupont, Claus Bus, Peter Lykke Eriksen, Karen Louise Thomsen, (unknown), Søren Nielsen, Charlotte Wilhelmina Wernberg, Mette Munk Lauridsen, Elisabetta Bugianesi, Chiara Rosso, Henning Grønbæk, Jørgen Kjems	0
2	Unbiased plasma profiling using pre-selected RNA aptamer pools predicts mortality in COVID-19 and identifies protein risk factors 2024 ·Molecular Therapy — Nucleic Acids ·(unknown), Daniel M. Dupont, (unknown), Claus Bus, Cecilie Bo Hansen, Thomas Benfield, Peter Garred, Peter M. H. Heegaard, Jørgen Kjems	0
3	Differential RNA aptamer affinity profiling on plasma as a potential diagnostic tool for bladder cancer 2022 ·NAR Cancer ·(unknown), Daniel M. Dupont, Claus Bus, Jan J. Enghild, Jørgen Bjerggaard Jensen, Karin Birkenkamp‐Demtröder, Lars Dyrskjøt, Jørgen Kjems	6
4	A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry 2021 ·Proceedings of the National Academy of Sciences ·Julián Valero, Laia Civit, Daniel M. Dupont, (unknown), Line S. Reinert, Manja Idorn, (unknown), (unknown), Claus Bus, Benedikt Asbach, David Peterhoff, Finn Skou Pedersen, Victoria Birkedal, Ralf Wagner, Søren R. Paludan, Jørgen Kjems	79
5	A screen of chemical modifications identifies position-specific modification by UNA to most potently reduce siRNA off-target effects 2010 ·Nucleic Acids Research ·Jesper B. Bramsen, Malgorzata Maria Pakula, Thomas B. Hansen, Claus Bus, Niels Langkjær, Dalibor Odadzic, Romualdas Smičius, (unknown), Jyoti Chattopadhyaya, Joachim W. Engels, Piet Herdewijn, Jesper Wengel, Jørgen Kjems	154
6	Synthesis of 2′-O-modified adenosine building blocks and application for RNA interference 2007 ·Bioorganic & Medicinal Chemistry ·Dalibor Odadzic, Jesper B. Bramsen, Romualdas Smičius, Claus Bus, Jørgen Kjems, Joachim W. Engels	41
7	T Cell Activation in 2002 ·Jan Liphardt, Serge Dumont, (unknown), (unknown), Claus Bus	1
8	Familial Alzheimer's disease co‐segregates with a Met 146 Ile substitution in presenilin‐1 1996 ·Clinical Genetics ·Poul Jørgensen, Claus Bus, Niels Pallisgaard, (unknown), Arne Lund Jørgensen	18
9	47 Familial Alzheimer's disease co-segregates with a MET146ILE substitution in presenilin-1 1996 ·Neurobiology of Aging ·Poul Jørgensen, Claus Bus, Niels Pallisgaard, (unknown), A L Jørgensen	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact